These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nontransferrin-bound serum iron in thalassemia and sickle cell patients. Ahmed NK, Hanna M, Wang W. Int J Biochem; 1986; 18(10):953-6. PubMed ID: 3792614 [Abstract] [Full Text] [Related]
11. The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Breuer W, Ronson A, Slotki IN, Abramov A, Hershko C, Cabantchik ZI. Blood; 2000 May 01; 95(9):2975-82. PubMed ID: 10779448 [Abstract] [Full Text] [Related]
16. Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia. Cossu P, Toccafondi C, Vardeu F, Sanna G, Frau F, Lobrano R, Cornacchia G, Nucaro A, Bertolino F, Loi A, De Virgiliis S, Cao A. Eur J Pediatr; 1981 Nov 01; 137(3):267-71. PubMed ID: 7318837 [Abstract] [Full Text] [Related]
17. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT. Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308 [Abstract] [Full Text] [Related]